(VIANEWS) – AHOLD DEL (AD.AS), LECTRA (LSS.PA), BOIRON (BOI.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio as yet. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. AHOLD DEL (AD.AS)
56.54% Payout Ratio
Koninklijke Ahold Delhaize N.V. operates retail food stores and e-commerce in the United States, Europe, and internationally. The company's stores offer produce, dairy, meat, deli, bakery, seafood, and frozen products; grocery, beer, and wine; floral, pet food, health and beauty care, kitchen and cookware, gardening tools, general merchandise articles, electronics, newspapers and magazines, tobacco, etc.; gasoline; and pharmacy products. It operates its supermarkets, convenience stores, and online stores under the Food Lion, Stop & Shop, The GIANT Company, Hannaford, Giant Food, FreshDirect, Albert Heijn, bol.com, Etos, Gall & Gall, Delhaize, Albert, Alfa Beta Vassilopoulos, Mega Image, Delhaize Serbia, Peapod Digital labs, and Retail Business Service brands. The company was formerly known as Koninklijke Ahold N.V. and changed its name to Koninklijke Ahold Delhaize N.V. in July 2016. Koninklijke Ahold Delhaize N.V. was founded in 1867 and is headquartered in Zaandam, the Netherlands.
Earnings Per Share
As for profitability, AHOLD DEL has a trailing twelve months EPS of €1.91.
PE Ratio
AHOLD DEL has a trailing twelve months price to earnings ratio of 14.76. Meaning, the purchaser of the share is investing €14.76 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.83%.
Sales Growth
AHOLD DEL’s sales growth for the current quarter is 1%.
Yearly Top and Bottom Value
AHOLD DEL’s stock is valued at €28.20 at 02:10 EST, way below its 52-week high of €31.88 and way higher than its 52-week low of €25.40.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 12, 2024, the estimated forward annual dividend rate is 1.22 and the estimated forward annual dividend yield is 4.42%.
More news about AHOLD DEL.
2. LECTRA (LSS.PA)
54.55% Payout Ratio
Lectra SA provides industrial intelligence solutions for fashion, automotive, and furniture markets in Northern Europe, Southern Europe, the Americas, and the Asia Pacific. The company designs, manufactures and markets end-to-end integrated technology solutions, which combines software, automated cutting equipment, and data, as well as associated services, including technical maintenance, support, training, and consulting. It also sells consumables and parts for its automated cutting equipment. Lectra SA was incorporated in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, LECTRA has a trailing twelve months EPS of €0.91.
PE Ratio
LECTRA has a trailing twelve months price to earnings ratio of 35.55. Meaning, the purchaser of the share is investing €35.55 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.42%.
Volume
Today’s last reported volume for LECTRA is 8655 which is 55.78% below its average volume of 19573.
More news about LECTRA.
3. BOIRON (BOI.PA)
53.4% Payout Ratio
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €2.74.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 12.27. Meaning, the purchaser of the share is investing €12.27 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.15%.
Yearly Top and Bottom Value
BOIRON’s stock is valued at €33.62 at 02:10 EST, way below its 52-week high of €56.50 and way higher than its 52-week low of €29.30.
Volume
Today’s last reported volume for BOIRON is 1545 which is 88.44% below its average volume of 13371.
More news about BOIRON.
4. ARCADIS (ARCAD.AS)
41.57% Payout Ratio
Arcadis NV offers design, engineering, and consultancy solutions for natural and built assets in The Americas, Europe, the Middle East, and the Asia Pacific. It operates through Places, Mobility, Resilience, and Intelligence segments. The company offers architectural and urbanism services; and asset management services, such as asset management strategy and planning, asset management decision making and operational optimization, life cycle planning and asset management systems, asset information/condition assessment, risk and review, organization and people, and asset management/O&M. It also provides business advisory services, including asset strategy and performance, business transformation and resiliency, investment and finance, operations and maintenance, and technology and information; contract solutions; cost and commercial management services; and design and engineering solutions for highways, railways, bridges, tunnels, power utilities, water utilities, ports and waterways, geotechnics, architecture, and structures, as well as building mechanical, electrical, and plumbing. In addition, the company offers digital environmental health safety and sustainability, environmental restoration, and project management solutions. Further, it provides mobility solutions for connected highways, intelligent rail and transit, integrated airports, and new mobility; places solutions; resilience solutions, such as energy transition, climate adaption, water optimization, enviro socio permitting, sustainable advisory, environmental restoration, and sustainable operations; and water supply and treatment, distribution, resource management, and industrial water and wastewater services. The company was formerly known as Heidemij NV and changed its name to Arcadis N.V. in October 1997. Arcadis NV was founded in 1888 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ARCADIS has a trailing twelve months EPS of €1.78.
PE Ratio
ARCADIS has a trailing twelve months price to earnings ratio of 33.46. Meaning, the purchaser of the share is investing €33.46 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.53%.
Volume
Today’s last reported volume for ARCADIS is 32979 which is 85.45% below its average volume of 226745.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.8%, now sitting on 5B for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 10, 2024, the estimated forward annual dividend rate is 0.85 and the estimated forward annual dividend yield is 1.44%.
Yearly Top and Bottom Value
ARCADIS’s stock is valued at €59.55 at 02:10 EST, below its 52-week high of €62.70 and way above its 52-week low of €37.24.
More news about ARCADIS.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Volatility
1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.
1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).
Volume
Today’s last reported volume for 1 is 1 which is 1% above its average volume of 1.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
More news about 1.
